Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant

Authors

J. Hiemenz, Florida Hospital Cancer Institute
P. Cagnoni, University of Colorado at Denver and Health Sciences Center
D. Simpson, Rush-Presbyterian-St.Luke's Medical Center
S. Devine, Washington University School of Medicine in St. Louis
N. Chao, Duke University
J. Keirns, Fujisawa Healthcare, Inc.
W. Lau, Fujisawa Healthcare, Inc.
D. Facklam, Fujisawa Healthcare, Inc.
D. Buell, Fujisawa Healthcare, Inc.

Journal

Antimicrobial Agents and Chemotherapy

Publication Date

2005

Volume

49

Issue

4

Inclusive Pages

1331

Document Type

Open Access Publication

DOI

10.1128/AAC.49.4.1331-1336.2005

Rights and Permissions

Hiemenz, J., Cagnoni, P., Simpson, D., Devine, S., Chao, N., Keirns, J., . . . Buell, D. (2005). Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant. Antimicrobial Agents and Chemotherapy, 49(4), 1331-1336. DOI: 10.1128/AAC.49.4.1331-1336.2005

Recommended Citation

Hiemenz, J.; Cagnoni, P.; Simpson, D.; Devine, S.; Chao, N.; Keirns, J.; Lau, W.; Facklam, D.; and Buell, D., "Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant." Antimicrobial Agents and Chemotherapy. 49, 4. 1331. (2005).
https://digitalcommons.wustl.edu/open_access_pubs/2358